89bio Inc

89bio Inc

ETNB - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.2B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
89bio Inc89bio Inc-4.2--86%--
$0.85

Current Fair Value

94.3% downside

Overvalued by 94.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.20 Billion
Enterprise Value$2.07 Billion
Earnings per Share$-3.51
Beta1.26
Outstanding Shares157,880,203

Return

Return on Equity-86.29%ROE
Return on Assets-74.60%
Return on Invested Capital-81.06%

Valuation & Multiples

P/E Ratio-4.23P/E Ratio
PEG-3.19PEG
Price to Sales-Price to Sales
Price to Book Ratio4.95Price to Book Ratio
Enterprise Value to Revenue98721.26
Enterprise Value to EBIT-4.54
Enterprise Value to Net Income-5
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 6, 2025
EPS Estimate
$-0.50
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 8.38, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.

Put/Call Ratio8.3776▲ 298.88%
Total Calls773,900▲ 158.48%
Total Puts6,483,397▲ 301.85%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %97.98%▼ 4.12%
Total Invested$2.27B▲ 43.61%
Investors Holding227▲ 25.00%

About 89bio Inc

89bio Insider Information FAQ

In the latest 13F quarter on Stockcircle, 6 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.